BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29022692)

  • 1. Paper Spray Ionization Coupled to High Resolution Tandem Mass Spectrometry for Comprehensive Urine Drug Testing in Comparison to Liquid Chromatography-Coupled Techniques after Urine Precipitation or Dried Urine Spot Workup.
    Michely JA; Meyer MR; Maurer HH
    Anal Chem; 2017 Nov; 89(21):11779-11786. PubMed ID: 29022692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MS
    Michely JA; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):158-163. PubMed ID: 28755512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dried urine spots - A novel sampling technique for comprehensive LC-MS
    Michely JA; Meyer MR; Maurer HH
    Anal Chim Acta; 2017 Aug; 982():112-121. PubMed ID: 28734350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-HR-MS/MS standard urine screening approach: Pros and cons of automated on-line extraction by turbulent flow chromatography versus dilute-and-shoot and comparison with established urine precipitation.
    Helfer AG; Michely JA; Weber AA; Meyer MR; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1043():138-149. PubMed ID: 27381570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening - exemplified for cardiovascular drugs.
    Helfer AG; Michely JA; Weber AA; Meyer MR; Maurer HH
    Anal Chim Acta; 2015 Sep; 891():221-33. PubMed ID: 26388381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
    Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated analysis of dried urine spot (DUS) samples for toxicology screening.
    Pablo A; Breaud AR; Clarke W
    Clin Biochem; 2020 Jan; 75():70-77. PubMed ID: 31707014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
    Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
    Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicological Drug Screening using Paper Spray High-Resolution Tandem Mass Spectrometry (HR-MS/MS).
    McKenna J; Jett R; Shanks K; Manicke NE
    J Anal Toxicol; 2018 Jun; 42(5):300-310. PubMed ID: 29377996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a liquid chromatography-tandem mass spectrometry (LC-MS/MS) procedure for screening of urine specimens for 100 analytes relevant in drug-facilitated crime (DFC).
    Remane D; Wetzel D; Peters FT
    Anal Bioanal Chem; 2014 Jul; 406(18):4411-24. PubMed ID: 24817357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sensitive electromembrane extraction for the determination of volatile organic compound metabolites in dried urine spot.
    Suh JH; Eom HY; Kim U; Kim J; Cho HD; Kang W; Kim DS; Han SB
    J Chromatogr A; 2015 Oct; 1416():1-9. PubMed ID: 26385086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of multiple drugs of abuse and metabolites in urine using LC/MS/MS with polarity switching electrospray ionization.
    Shin M; Ji D; Kang S; Yang W; Choi H; Lee S
    Arch Pharm Res; 2014 Jun; 37(6):760-72. PubMed ID: 23918650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous detection of 19 drugs of abuse on dried urine spot by liquid chromatography-tandem mass spectrometry.
    Lee Y; Lai KKY; Sadrzadeh SMH
    Clin Biochem; 2013 Aug; 46(12):1118-1124. PubMed ID: 23583348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry.
    Saleh A; Stephanson NN; Granelli I; Villén T; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():6-13. PubMed ID: 23153637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
    Sundström M; Pelander A; Ojanperä I
    Drug Test Anal; 2015 May; 7(5):420-7. PubMed ID: 24953563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of two LC-MS/MS methods for the detection and quantification of amphetamines, designer amphetamines, benzoylecgonine, benzodiazepines, opiates, and opioids in urine using turbulent flow chromatography.
    Schaefer N; Peters B; Schmidt P; Ewald AH
    Anal Bioanal Chem; 2013 Jan; 405(1):247-58. PubMed ID: 23076398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution full scan liquid chromatography mass spectrometry comprehensive screening in sports antidoping urine analysis.
    Abushareeda W; Vonaparti A; Saad KA; Almansoori M; Meloug M; Saleh A; Aguilera R; Angelis Y; Horvatovich PL; Lommen A; Alsayrafi M; Georgakopoulos C
    J Pharm Biomed Anal; 2018 Mar; 151():10-24. PubMed ID: 29291455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LC-MS-MS vs ELISA: Validation of a Comprehensive Urine Toxicology Screen by LC-MS-MS and a Comparison of 100 Forensic Specimens.
    Kahl KW; Seither JZ; Reidy LJ
    J Anal Toxicol; 2019 Oct; 43(9):734-745. PubMed ID: 31424082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.